Publications - July 2021
Preprint and peer-reviewed publications from RECOVER’s studies
Future pandemic preparedness efforts should focus on building
interdisciplinary collaboration within advisory boards; ensuring transparency in how boards operate;
defining and protecting boundaries of the scientific advisor role; and supporting scientists to inform
the public in the fight against disinformation, whilst dealing with potential hostile reactions.
This study investigates the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with COVID-19. Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The results show that, among critically ill patients with COVID-19, lopinavir-ritonavir, hydroxychloroquine, or combination therapy worsened outcomes compared to no antiviral therapy.